
http://www.mmm-online.com/campaigns/mercks-creative-archive-tells-an-industry-story/article/526004/
http://www.dailypolitical.com/2016/10/02/shinko-asset-management-co-ltd-has-409000-stake-in-merck-co-mrk.html
http://www.dailypolitical.com/2016/10/02/merck-co-mrk-stake-increased-by-brick-kyle-associates.html
http://www.dailypolitical.com/2016/10/02/merck-co-mrk-stake-maintained-by-bush-odonnell-investment-advisors-inc.html
http://www.mb.com.ph/potential-new-first-line-treatment-for-lung-cancer-bared/
http://www.sandiegouniontribune.com/business/biotech/sd-me-celgene-abide-20161003-story.html
http://www.sacbee.com/news/politics-government/capitol-alert/article105299831.html
http://www.finanznachrichten.de/nachrichten-2016-10/38751178-clintec-international-wins-scale-up-business-of-the-year-award-at-the-2016-minority-supplier-development-network-uk-awards-004.htm

http://www.adnkronos.com/immediapress/chimica-e-farmacia/2016/10/03/eisai-enrols-patients-global-phase-carcinoma-trial-evaluate-first-line-kisplyx-lenvatinib-plus-pembrolizumab-everolimus-versus-sunitinib-advanced-renal-cell_8NdfjVZRKTpGC9y8NyEAVJ.html
http://www.getrichslowly.org/blog/2016/09/06/whats-the-cure-for-the-high-cost-of-prescriptions/
http://www.aarp.org/health/brain-health/info-2016/treating-alzheimers-symptoms-can-lower-care-costs-rr.html
http://www.presseportal.de/pm/80515/3445755
http://www.prnewswire.co.uk/news-releases/eisai-enrols-patients-in-global-phase-iii-trial-to-evaluate-first-line-kisplyx-lenvatinib-plus-pembrolizumab-or-everolimus-versus-sunitinib-in-advanced-renal-cell-carcinoma1-595580051.html
http://www.finanznachrichten.de/nachrichten-2016-10/38744520-eisai-enrols-patients-in-global-phase-iii-trial-to-evaluate-first-line-kisplyx-lenvatinib-plus-pembrolizumab-or-everolimus-versus-sunitinib-in-adva-008.htm
https://www.yahoo.com/news/factbox-biosimilar-landscape-cluttered-big-pharma-lawsuits-091229927--finance.html
http://www.marketwatch.com/story/companion-animals-drug-market-global-industry-analysis-and-opportunity-assessment-2015---2025-2016-10-03
http://www.prnewswire.com/news-releases/oral-contraceptive-pills-market---global-industry-analysis-size-share-growth-trends-and-forecast-2015---2023-300338372.html
http://www.prnewswire.com/news-releases/menopausal-hot-flashes-market-non-hormonal-global-industry-analysis-size-share-growth-trends-and-forecast-2015---2023-300338360.html
http://www.marketwatch.com/story/oral-contraceptive-pills-market---global-industry-analysis-size-share-growth-trends-and-forecast-2015---2023-2016-10-03
https://consumerist.com/2016/10/03/after-confusion-over-epipen-profits-lawmakers-want-proof-of-drugs-actual-costs/
http://www.4-traders.com//news/Global-Ophthalmology-Drugs-Market-Analysis-2016-Forecast-to-2022-Research-and-Markets--23155170/
http://www.eurekalert.org/pub_releases/2016-10/no-iac100316.php
http://thehill.com/business-a-lobbying/298803-top-democratic-staffer-joins-capitol-counsel
http://www.prnewswire.com/news-releases/preliminary-data-from-the-ongoing-open-label-xmab5871-phase-2-pilot-study-in-igg4-related-disease-to-be-presented-at-american-college-of-rheumatology-acr-2016-annual-meeting-300337797.html
http://www.ishn.com/articles/104998-sog-seeks-more-deal-with-it-cultural-safety-training-partners-in-us-following-agreement-with-circle-safety
http://www.mmm-online.com/payersmanaged-markets/power-to-the-payers-pbms-leave-behind-a-trail-of-tiers/article/526109/
http://www.mmm-online.com/commercial/how-five-therapies-changed-the-course-of-pharma-history/article/526001/
http://www.mmm-online.com/campaigns/30-years-later-dtcs-complicated-past-still-hasnt-deterred-marketers/article/526019/
http://www.pr-inside.com/prothena-announces-appointment-of-dr-gene-g-kinney-r4531064.htm
http://www.finanznachrichten.de/nachrichten-2016-10/38748492-prothena-corporation-plc-prothena-announces-appointment-of-dr-gene-g-kinney-as-president-chief-executive-officer-and-director-252.htm
http://news.trust.org/item/20161003090232-nd274/
http://economictimes.indiatimes.com/news/international/business/big-pharma-vs-big-pharma-in-court-battles-over-biosimilar-drugs/articleshow/54640324.cms
http://news.trust.org/item/20161002090237-6j5hd/


http://www.theage.com.au/lifestyle/health-and-wellbeing/patients-with-severe-eczema-welcome-relief-from-new-drug-dupilumab-20161003-grtoe8.html
http://www.adnkronos.com/immediapress/pr-newswire/2016/10/03/eisai-enrols-patients-global-phase-carcinoma-trial-evaluate-first-line-kisplyx-lenvatinib-plus-pembrolizumab-everolimus-versus-sunitinib-advanced-renal-cell_8NdfjVZRKTpGC9y8NyEAVJ.html
